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MICROARRAY ANALYSIS OF MOUSE LUNG EXAMINING THE 
AUGMENTED PSEUDOMONAS AERUGINOSA CLEARANCE FOLLOWING 
MILD TRAUMATIC BRAIN INJURY 
MAX VAICKUS 
ABSTRACT 
 Our murine model of mild traumatic brain injury (mTBI) has shown improved 
survival after Pseudomonas aeruginosa (Psd) challenge as compared to controls (tail 
trauma or sham injury). Previous work suggests an mTBI-specific involvement of the 
neuro-immune axis which augments the innate immune response, increasing survival. 
Additional factors for the enhanced mTBI survival were explored via microarray analysis 
of lungs harvested 48 hours post-trauma, the point prior to Psd challenge in our model. At 
48 hours post-trauma, mTBI lungs have a number of upregulated ATP synthesis and 
mitochondrial gene sets. Increased available energy could prime the mTBI lungs, 
allowing an earlier and more robust response to Psd infection, possibly contributing to 
the increased mTBI survival. This is supported by increased neutrophil recruitment in the 
bronchoalveolar lavage of mTBI mice four hours after Psd instillation. Downregulated 
gene sets related to cellular connections suggest that neutrophils recruited to the lung 
have an easier extravasation pathway into the air space of mTBI lungs compared to 
control. Based on genetic and neutrophil recruitment data, it is possible that mTBI creates 
an energetically prepared and easily accessible lung better tailored for recruiting and 
allowing entry of neutrophils in response to an infection compared to control. 
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INTRODUCTION 
Traumatic brain injury (TBI) is a serious global health issue responsible for close 
to 2.5 million emergency department visits per year 
1
. A TBI can trigger a series of 
complicated physiological events which have repercussions far beyond the initial injury, 
often causing permanent alterations in the brain and increasing the incidence of chronic 
pathological diseases such as seizures, sleep disorders, and psychiatric diseases, amongst 
other complications
2
. However, the full range of the repercussions of a TBI, and their 
mechanisms, are still relatively unknown. There are three levels of TBI: mild, moderate, 
and severe. Our research is focused on mild traumatic brain injury (mTBI) as it is the 
most common TBI in humans
3
.  mTBI includes concussions and sub concussive forces 
and even though mTBI is the least severe of TBIs, it still results in a “neurometabolic 
cascade of concussion”4 which releases neurotransmitters and causes fluctuations in ionic 
balances. In addition to the cerebral metabolic alterations, inflammatory and 
immunological responses are stimulated
5
. Following injury, recruitment of immune and 
glial cells to the site of trauma is increased by upregulation of the cell adhesion molecules 
P-selectin, ICAM-1, and VCAM-1
5
. The local infiltration of leukocytes is aided by the 
release of proinflammatory cytokines like TNF, IL-1β, and IL-6 shortly after injury6. 
However, these cytokines can initiate a cascade of events downstream of the mTBI, 
resulting in systemic alterations in the organism. 
While any TBI may be harmful to the general public, further analysis of the 
downstream mTBI consequences suggests that not all physiological responses may be 
detrimental, as evidenced by Yang et al. (2010). Amongst patients hospitalized for non-
 2 
head trauma or mTBI who developed pneumonia, the mTBI patients showed increased 
survival
7
. This interesting clinical observation initiated the development of a murine 
model of mTBI to further investigate the novel survival findings and attempt to replicate 
them
7
. The mouse model of mTBI developed in our laboratory, compared to a control 
blunt trauma localized to the tail, was able to replicate the same increased survival to 
pneumonia of subjects hospitalized with brain trauma versus blunt trauma as was 
observed in the human cohort
7, 8
. This mouse model of mTBI is the model used in this 
thesis. Combined with the increased survival of mTBI mice, there was increased 
recruitment of polymorphonuclear leukocytes (PMN) to the lung space
7
 as well as 
enhanced killing of bacteria by the immune system of the mTBI mice compared to the 
control tail trauma (TT) mice. The increased survival and enhanced innate immune 
response of the mTBI mice compared to the TT mice when challenged with pneumonia 
raises questions as to the mechanism responsible. Initial analyses of the counterintuitive 
results are thought to be related to the neuropeptide Substance P (SP).  
Previous studies
8,7
 suggest that SP, an eleven amino acid neuropeptide which acts 
through the tachykinin neurokinin-1 receptor (NK1R), plays an important role in 
augmenting the immune response after mTBI. It is believed that following mTBI, SP is 
released from the site of injury and acts on the NK1Rs throughout the organism. Other 
neurokinin receptors exist (NK2R and NK3R), and depending on concentrations of SP 
and receptor availability, SP can act through them. However, SP acts preferentially on 
NK1R
9
. SP is known to recruit inflammatory cells into tissues either through its effect on 
the tissue’s NK1Rs (vasodilation) or the inflammatory cell’s NK1Rs (chemotaxis)10. Our 
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interest in SP for our mTBI model is focused on its chemotactic properties on neutrophils 
and other immune responders, which are well documented
11,12,13
. The hypothesis for the 
role of released SP from the mTBI acting on the NK1Rs throughout the mouse to 
enhance survival and immune response is supported by NK1R agonist and antagonist 
studies
8
. When the mTBI mice were treated with an NK1R antagonist, then challenged 
with bacteria, the increased survival effect was not seen, supporting the importance of SP 
as a principal mediator of the increased survival of the mTBI mice.  
While previous studies in our lab explore the role of SP in this augmented 
immune response, this study will examine the genetic changes induced in the lung after 
mTBI which could contribute to the augmented immune response and increased survival. 
The design of the current study is as follows (Figure 1), mice receive mTBI or TT and 48 
hours later, are sacrificed. The lungs are removed and homogenized so RNA can be 
extracted. The RNA is then run on a microarray chip for analysis of genetic changes. The 
RNA of the lung is analyzed at 48 hours for two reasons. First, 48 hours is the usual 
timeline of pneumonia development in the human cohort of previous studies. Second, our 
previously published work administered Pseudomonas aeruginosa (Psd) 48 hours after 
mTBI or TT. The purpose of this study is to identify any possible differences in the 
genetic landscape of the site of infection between mTBI and TT at the point immediately 
prior to the pathogenic insult. 
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Figure 1: Design of current study. Mice receive mTBI (n=2) or TT control (n=3) and 48 
hours later, at the time point mice usually receive Psd, lungs are harvested and RNA is 
extracted for microarray analysis. This is done to determine any genetic influences which 
could contribute to the usual model’s results. We hypothesize that the changes in the gene 
expression of mTBI lungs could contribute to the increased survival of the mTBI mice 
when they receive Psd 48 hours after trauma in our usual model. 
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METHODS  
 
Animals 
Female ICR (CD-1) mice (Harlan Laboratories, Inc., Frederick, MD) were used in 
all experiments. Mice could access food and water ad libitum for the entire study. 
Animals were housed in a room set on a diurnal 12 hour light-dark cycle that was 
temperature and humidity controlled. They were allowed to acclimate for at least 72 
hours before any experiments. All mice were 24-30g and at least 8-10 weeks old. All 
experiments were approved by the Boston University Institutional Animal Care and Use 
Committee. 
Trauma model 
Mild traumatic brain injury (mTBI) was performed as previously described
7
. 
Under isoflurane anesthesia, mice were placed prone on a Plexiglas bed with their head 
resting on a foam pad under a 170g steel rod encased in a guide tube. The rod is dropped 
from 5.2 cm above the skull to impact a point in the midline of the skull, producing a 
5kg/cm
2
 impact force halfway between the interauricular and interorbital lines.  Rebound 
impact is prevented and mice were immediately injected subcutaneously with 0.05 mg/kg 
buprenorphine in 1 ml of warmed normal saline. Mice were placed supine on a warming 
bed until recovered and able to right themselves. The control trauma model, Tail Trauma 
(TT), was performed as previously described 
8
. TT was induced by placing isoflurane-
anesthetized mice in a prone position under the weight drop mTBI apparatus. The 170g 
rod was dropped from a height of 8.5 cm on the tail 2 cm from the base. TT mice 
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received the same buprenorphine dose and were placed on the warming bed before 
returning to their cages after righting themselves. 
RNA Extraction 
Mice were anesthetized with isoflurane, xylazine/ketamine and exsanguinated via 
retro-orbital bleeding. All mice underwent bronchoalveolar lavage (BAL) with 1 ml of a 
50:1 HBSS/EDTA mixture (169 mM EDTA). The lavage fluid was spun and supernatant 
was frozen for later analysis. After BAL, two random sections of the right lung were 
sampled from the superior and inferior lobe of each mouse to introduce randomization 
and heterogeneity of the tissue sample collected. The left lung was perfused with 
formalin and removed for later histology. The right lung sections were stored in 
RNAlater (Thermo Fisher Scientific, Waltham, MA) overnight. After RNAlater fixation, 
a section from each of the two lung samples were placed in 600 μL of buffer RLT 
(Qiagen, Hilden, Germany) with 6 μL of 14.3 M beta-mercaptoethanol (Sigma)  then 
homogenized using the TissueLyser II at 30 Hz for four minutes. RNA was then 
extracted from the homogenate using the QiaCube equipped with the RNeasy Plus Mini 
Kit. 
cDNA 
The RNA concentration was measured using a Nanodrop 2000c (Thermo 
Scientific) blanked with pH 8.0 Tris-EDTA (Fisher, Hampton, New Hampshire). The 
stock RNA solution was diluted 5x with Tris-EDTA before sampling for concentration. 
After determining concentrations, tubes with a total final volume of 14 μL were made for 
each sample so that there was 1000 ng of RNA in each tube. The remaining volume was 
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brought to 14 μL with water. The DNA was eliminated and cDNA transcribed according 
to manufacturer’s instructions for the QuantiTect Reverse Transcriptase Kit (Qiagen). 
Real Time PCR (RT-PCR) for Neurokinin-1 Receptor (NK1R) 
As a preliminary control to assess that gene expression differences are detected 
using our model and that our RNA extraction method is valid, a housekeeping gene and a 
gene we believe would change based on previous work were quantified in a mTBI and 
TT mouse, prior to running the analysis on the microarray chips. Hypoxanthine-guanine 
phosphoribosyltransferase (HPRT) forward and reverse primers were used as the 
housekeeping gene, NK1R forward and reverse primers (Table 1) were used as the gene 
expected to change due to our previous work which saw differences when the NK1R was 
modulated
8
. The mRNA transcripts were quantified from the cDNA using RT-PCR. 
Primers were purchased from Integrated DNA Technologies (Coralville, Iowa).  
Table 1. Forward and reverse primer sequences of the tested HPRT housekeeping gene 
and NK1R gene. 
Gene Sequence 
HPRT forward 5’-TCG GCT TAC CTC ACT GCT TTC-3’ 
HPRT reverse 5’-CCT GGT TCA TCA TCG CTA AT-3’ 
NK1R forward 5’-GAT ACC TCC AGA CCC AGA G-3’ 
NK1R reverse 5’-GCT GGA GCT TTC TGT CAT G-3’ 
 
A 55 μL master mix was created using the QuantiFast SYBR Green PCR Kit (Qiagen) 
that consisted of 25% SYBR Green, 10% forward primer, 10% reverse primer, and 45% 
water. 49.5 μL of this master mix was added to each tube (tubes were run in duplicate 
with a negative of just master mix, and positive control of naïve mesenteric lymph node 
RNA). 5.5 μL of the cDNA sample (10% of final volume of 55 μL) was added to each 
tube. 25 μL of the 55 was split into duplicates. HPRT and NK1R were then run according 
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to manufacturer’s instructions on the StepOnePlus RT PCR (Applied Biosystems, Foster 
City, CA) 
Microarray 
General procedure, normalization, and quality assessment 
The procedure and subsequent analysis were run at the Boston University 
Microarray and Sequencing Resource Core Facility, funded by CTSA grant UL1-
TR001430. The following methods for the microarray procedure are compiled with the 
help of the BU Microarray Core technicians Adam Gower and Eduard Drizik. All 
microarray analyses were performed using the R environment for statistical computing 
(version 2.15.1). Gene microarray analysis was run on a mouse Affymetrix GeneChip® 
Gene 1.0ST Array System. Mouse Gene 1.0 ST CEL files were normalized to produce 
gene-level expression values using the implementation of the Robust Multiarray Average 
(RMA)
14
 in the “affy” R package (version 1.36.1)15 included in the Bioconductor 
software suite (version 2.12)
16
 and an Entrez Gene-specific probeset mapping (17.0.0) 
from the Molecular and Behavioral Neuroscience Institute (Brainarray) at the University 
of Michigan
17, 18
. Array quality was assessed by computing Relative Log Expression 
(RLE) and Normalized Unscaled Standard Error (NUSE) using the “affyPLM” package 
(version 1.34.0)
19
. RLE is a measure of the relative quality of each sample (how much the 
signal was artificially boosted during normalization) compared to other arrays in the 
batch. NUSE is a measure of the relative agreement between a sample’s probes for each 
gene, compared to the other arrays in the batch. For each sample, median RLE values > 
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0.1 or NUSE values > 1.05 are considered out of usual limits. All arrays had median RLE 
and NUSE values within these limits, suggesting samples of similar quality.  
Principal Component Analysis (PCA) was performed using the “prcomp” R 
function with values normalized across all samples to a mean of zero and a standard 
deviation of one. Differential expression was assessed using the moderated (empirical 
Bayesian) t test implemented in the “limma” R package (version 3.14.4). Correction for 
multiple hypothesis testing was accomplished using the Benjamini-Hochberg false 
discovery rate (FDR)
20
. Human homologs of mouse genes were identified using 
HomoloGene (version 68)
21
.  
Positive control gene expression 
The expression of several sex-specific genes (Xist, Ddx3y, Eif2s3y, Kdm5d, and 
Uty) was assessed to estimate the dynamic range of the array, as the female-specific 
marker Xist and constitutively expressed Y-linked genes serve as strong positive and 
negative expression controls in female animals, respectively (and vice versa in male 
animals). In all samples, the expression of Xist was high (~9 log2 units) and the 
expression of the Y-linked genes was very low (~2-3 log2 units), confirming that the mice 
used were female. This analysis also indicates that the experiment has good dynamic 
range to identify genes with true differential gene expression. 
Statistical analysis 
Pairwise t tests were performed for each gene between experimental groups to 
obtain a t statistic and p value for each gene. A "moderated" t test was used, which is a 
Bayesian analysis that does not test each gene independently, but rather, leverages 
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information from all of the genes on the array to increase statistical power over Student's 
two-sample t test. It was used because it is a helpful statistical analysis when sample sizes 
are small, as in this study. FDR correction was applied to obtain FDR-corrected p values 
(q values). The FDR q value was also recomputed after removing genes that were not 
expressed above the array-wise median value of at least one array. Genes with low 
overall expression are more strongly affected by random technical variation and more 
likely to produce false positive results. The value considered significant for the FDR q 
value (comparable to a p<0.05) is <0.25. Q values represent the probability that a given 
result is a false positive based on the distribution of all p values on the array. This implies 
that there is less than a 25% chance that the observed pattern between experimental 
groups is a false positive. Corrected/adjusted p values such as the FDR q are the best 
measure of significance for a given test when many genes are tested at once. All FDR q 
values mentioned will be less than <0.25, which is a good measure of significance given 
the breadth and sheer number of gene expression values which are factored into the FDR 
q value. 
Gene Set Enrichment Analysis (GSEA) 
GSEA (version 2.2.1)
22
 was used to identify biological terms, pathways and 
processes that are coordinately up- or down-regulated within each pairwise comparison. 
The Entrez Gene identifiers of the human homologs of the genes interrogated by the array 
were ranked according to the moderated t statistic computed between mTBI and TT. 
Mouse genes with multiple human homologs (or vice versa) were removed prior to 
ranking, so the ranked list represents only those human genes that match one mouse gene. 
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This ranked list was then used to perform pre-ranked GSEA analyses (default parameters 
with random seed 1234) using the Entrez Gene versions of the Hallmark, Biocarta, 
KEGG, Reactome, Gene Ontology (GO), and transcription factor and microRNA motif 
gene sets obtained from the Molecular Signatures Database (MSigDB), version 5.0
23
. 
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 RESULTS  
 
 
Microarray analysis - Principal Component Analysis (PCA) 
To analyze broad overall genetic differences between mTBI (n=3) and TT (n=3) 
lungs at 48 hours, the results of the microarray were analyzed via PCA. PCA is a 
mathematic algorithm which groups the genetic differences between samples across all 
21,187 probesets on the chip into smaller Principal Components (PC) so that larger 
differences can easily be viewed. The PC1 axis accounts for the most genetic variation. 
Unfortunately, the groups do not separate on this axis, suggesting that the largest 
differences between the groups are not due to the treatment. However, the groups 
revealed strong separation along the PC2 axis which suggests that 24% of all variance in 
the experiment is due to the biological consequences of mTBI versus TT on the lungs 
(Figure 2).  
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Figure 2. Plot of PC1 vs. PC2, computed across all genes. The PCA plot represents the 
broad differences in genetic expression of mTBI and TT RNA extracted from mouse 
lungs. mTBI n=3, TT n=3. 
 
However, further analysis of TBI 737, the sample which separates strongly from 
both groups, revealed that a piece of thymus or mediastinal lymph node could have been 
included with the lung as it was collected. We believe this to be the case as TBI 737 had 
abnormally high genetic expression of B cell and antibody related genes as compared to 
the other 5 mice (Figure 3). 
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Figure 3. Heatmap of the top 500 genes with largest variance across all samples. TBI 737 
has a large portion of genes at the top of the column heavily upregulated compared to all 
other samples. This is likely due to lymph node contamination as the genes within this 
section are all canonical B cell genes. 
 15 
The topmost part of TBI 737 column, which is the deepest red compared to all 
other mice in that particular gene set, shows that it is far more upregulated than other 
samples. The genes that are heavily upregulated in TBI 737 support the possible 
lymphatic tissue contamination as the genes within this deep red section are mostly 
canonical lymphocytic markers (Bcl11a, Blk, Btla, CD19, CD72, CD79a, CD79b, Ly6d, 
Ptpn22, Sell). Also, none of the other 5 mice showed any level of genetic upregulation 
close to TBI 737 in this set of genes, supporting our idea that the sample was 
contaminated. This lymphocytic contamination could explain the strong separation of 
TBI 737 along the PC1 axis. For this reason, we felt confident in excluding TBI 737 from 
the analysis as we were interested in changes in the lung only. 
Due to the tissue contamination and subsequent exclusion, we reran all analyses 
with TBI 737 excluded for a total of three TT and two mTBI mice (Figure 4). 
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Figure 4. Plot of PC1 vs. PC2, computed across all genes with TBI 737 removed due to 
contamination. Treatment groups now separate strongly with 34% variance on the PC1 
axis, the axis which accounts for the most variation. mTBI n=2, TT n=3. 
 
When the data was rerun without the outlier skewing all the analysis, the PCA 
plot was rearranged so that the treatment groups still separated, but now on the PC1 axis, 
suggesting that 34% of the biological differences seen between mTBI and TT were due to 
the treatment. While the separation is not as visually striking as the original PCA plot, 
this is likely due to normal biological variability, and the new separation on the PC1 
between the groups is encouraging as the PC1 axis accounts for the most variation. From 
this point onward, all analyses and discussions will be with the TBI 737 outlier removed. 
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Microarray analysis- Gene Set Enrichment Analysis (GSEA) – Upregulated gene sets 
in mTBI 
GSEA groups sets of genes which are coordinately up or down regulated with 
respect to a given comparison. The gene sets are related to biological pathways or 
processes and the genes included in my analysis are compared to publicly available gene 
sets at the Molecular Signatures Database 
(http://www.broadinstitute.org/gsea/msigdb/index.jsp). Within this database are gene sets 
which represent well-studied pathways and other gene sets generated by the Kyoto 
Encyclopedia of Genes and Genomes (KEGG), Gene Ontology (GO), Biocarta, and 
Reactome. The gene sets created by these four entities correspond to biological functions, 
locations, or pathways. A gene set that is significantly different between mTBI and TT 
with a p<0.05 and FDR q<0.25 suggests that the pathway or process could be changed as 
a result of the mTBI. Of the 433 total gene sets which had a p<0.05 and FDR q<0.25, 98 
were upregulated in mTBI compared to TT lungs.  
ATP synthesis 
Of the 94 upregulated gene sets, 20 are related to ATP synthesis or mitochondrial 
structure and function (Table 2). The most significantly upregulated gene sets are related 
to oxidative phosphorylation, an example of which is seen in Figure 5. 
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Table 2. 20 ATP synthesis or mitochondria related gene sets which are upregulated in 
mTBI lungs vs. TT with a FDR q<0.25. GSEA, Gene Set Enrichment analysis; NES, 
normalized enrichment score; P value <0.01; FDR (false discovery rate) Q <0.25 
GSEA Set Name NES Nomin
al 
P 
Value 
FDR Q 
Value 
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_
SYNTHESIS 
_BY_CHEMIOSMOTIC_COUPLING_ 
AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ 
2.86 0.000 0.0000 
KEGG_OXIDATIVE_PHOSPHORYLATION 2.68 0.0000 0.0000 
REACTOME_RESPIRATORY_ELECTRON_TRANSPORT 2.84 0.0000 0.0077 
REACTOME_TCA_CYCLE_AND_RESPIRATORY_ELECTRON_
TRANSPORT 
2.30 0.0000 0.0011 
MONOVALENT_INORGANIC_CATION_TRANSMEMBRANE_T
RANSPORTER_ACTIVITY 
1.80 0.0062 0.0831 
MITOCHONDRIAL_RIBOSOME 2.28 0.0000 0.0013 
MITOCHONDRIAL_PART 2.20 0.0000 0.0029 
MITOCHONDRIAL_MEMBRANE_PART 2.20 0.0000 0.0030 
MITOCHONDRIAL_ENVELOPE 2.03 0.0000 0.0168 
MITOCHONDRIAL_LUMEN 1.94 0.0000 0.0363 
MITOCHONDRIAL_MATRIX 1.92 0.0020 0.0 420 
MITOCHONDRIAL_MEMBRANE 1.87 0.0000 0.0561 
MITOCHONDRIAL_OUTER_MEMBRANE 1.84 0.0102 0.0705 
CELLULAR_RESPIRATION 1.84 0.0083 0.0683 
MITOCHONDRION 1.82 0.0000 0.0749 
REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT 1.77 0.0061 0.0970 
MITOCHONDRION_ORGANIZATION_AND_BIOGENESIS 1.67 0.0143 0.1532 
ELECTRON_CARRIER_ACTIVITY 1.57 0.0067 0.2237 
MITOCHONDRIAL_RESPIRATORY_CHAIN 1.55 0.0455 0.2355 
MITOCHONDRIAL_TRANSPORT 1.55 0.0342 0.2382 
MITOCHONDRIAL_INNER_MEMBRANE 1.54 0.0258 0.2463 
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Figure 5. Example of leading edge gene heatmap of the genes upregulated in mTBI 
(orange) vs. TT (gray) within the KEGG classified “Oxidative Phosphorylation” gene set. 
These are the leading edge genes within the set, meaning they contribute the most to the 
statistical significance of this set’s upregulation in mTBI (red and blue = upregulated and 
downregulated compared to mean expression, respectively). 
 
Other upregulated sets 
Our mTBI model provides an increased survival which we believe is partly the 
result of a neuro-immune response stemming from the brain injury. Our work has focused 
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on the neuropeptide Substance P (SP) however; there are broad effects of a brain injury 
which likely affect the immune response. In support of this, the “Neurotransmitter 
Receptor Activity” pathway is significantly upregulated with a FDR q<0.25 (0.196), 
suggesting that the receptors for messages originating from the brain are receiving 
instructions to upregulate in mTBI versus TT lungs. This could mean that the lungs of 
mTBI mice have more active neurotransmitter activity, so that they could be more 
receptive and responsive to any signals coming from the brain, like SP, which we believe 
is a central component of our increased survival. 
 Of interest in our model’s enhanced immune response to a Psd infection, 
“Biocarta Cytokine Pathway” and ”Reactome Downstream Signaling Events Of B Cell 
Receptor BCR” are upregulated in mTBI with a FDR q<0.25 (0.187, 0.197 respectively). 
While this particular microarray analysis is limited to measuring messages sent in the 
form of mRNA and not levels of actual protein, the “Reactome Activation of the mRNA 
Upon Binding of the Cap Binding Complex and EIFS and Subsequent Binding to 43S” 
and “Translation” pathways are all upregulated in mTBI versus TT with an FDR q<0.25. 
This indicates that the pathways involved in turning mRNA into protein could be more 
active in mTBI lungs than TT, suggesting the possibility that in mTBI lungs more so than 
TT lungs, these messages could be turned into protein (Figure 6). 
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Figure 6. Schematic representation of the mechanism likely to be more active based on 
upregulation of the gene sets “Reactome Activation of the mRNA Upon Binding of the 
Cap Binding Complex and EIFS and Subsequent Binding to 43S” and “Translation” in 
mTBI vs. TT lungs. Upregulation of these pathways imply that translation is more likely 
in the mTBI lungs as the pathways are integral steps to the production of protein. First, 
the mRNA binds to the cap binding complex (made of various eukaryotic initiation 
factors indicated by the bracket), then joins with the 43s pre-initiation complex to make 
the active 80s ribosome (40s/60s). After formation of the 80s ribosome, translation takes 
place, turning the mRNA into protein. The genes included in the pathways making this 
mechanism imply that mTBI is more likely to produce protein than TT lungs because the 
genes constituting these mechanisms are upregulated mTBI mice vs. TT (adapted from 
Silvera et al., 2010
24
). 
 
Microarray analysis- Gene Set Enrichment Analysis (GSEA) – Downregulated gene 
sets in mTBI 
Integrin, extracellular matrix, adhesion molecules 
In mTBI lungs, there are multiple downregulated gene sets related to inter-cell, 
intra-cell, and extracellular connections and organization (Table 3). Our published data of 
increased neutrophil counts in the lungs of mTBI versus TT lungs after pathogen 
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challenge is supported by these downregulated gene sets. This genetic change supports 
the idea that the mTBI lungs immediately prior to infection are “leakier” than TT lungs, 
possibly allowing for easier extravasation of the recruited immune responders from 
circulation into the air space. We believe this less impeded entry into the airspace upon 
pathogen challenge, on account of the leakier lungs, is another factor supporting the 
increased survival of mTBI mice compared to TT. 
Table 3. Gene sets related to inter-cell, intra-cell, and extracellular connections and 
organization downregulated in mTBI vs. TT lungs with a FDR q<0.25. NES, normalized 
enrichment score; P value <0.01; FDR (false discovery rate) Q <0.25 
GSEA Set Name NES Nominal 
P Value 
FDR Q 
Value 
KEGG_CELL_ADHESION_MOLECULES_CAMS -1.9 0.000 0.0490 
CELL_SUBSTRATE_ADHESION -1.56 0.036 0.1760 
CELL_MATRIX_ADHESION  -1.58 0.020 0.1234 
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON -1.8 0.000 0.0763 
KEGG_ADHERENS_JUNCTION -1.71 0.000 0.0676 
ACTIN_BINDING -1.71 0.004 0.0682 
REACTOME_CELL_JUNCTION_ORGANIZATION -1.73 0.002 0.0606 
CELL_SURFACE -1.74 0.000 0.0540 
REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS -1.88 0.002 0.0204 
ACTIN_CYTOSKELETON -1.93 0.000 0.0151 
INTEGRIN_BINDING -1.96 0.000 0.0120 
EXTRACELLULAR_REGION -2.02 0.000 0.0065 
INTEGRIN_COMPLEX -2.08 0.000 0.0033 
BASEMENT_MEMBRANE -2.41 0.000 0.0002 
STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON -1.67 0.010 0.1211 
COLLAGEN -2.1 0.002 0.0152 
KEGG_FOCAL_ADHESION -2.36 0.000 0.0000 
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS -2.7 0.000 0.0000 
REACTOME_COLLAGEN_FORMATION -2.94 0.000 0.0000 
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION -2.83 0.000 0.0000 
KEGG_ECM_RECEPTOR_INTERACTION -2.70 0.000 0.0000 
 
Glycosaminoglycans (GAG) 
GAGs are known to aid in cell migration and Psd pathogenesis by facilitating 
attachment to the host, amongst other functions
25,26
. mTBI mice had downregulated GAG 
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metabolism pathways, which could make their lungs a more difficult environment for Psd 
to establish an infection. Heparin, a GAG, is thought to inhibit cell migration of 
leukocytes
27
, with heparin metabolism pathways downregulated in mTBI lungs prior to 
infection; the leukocytes in an mTBI lung could migrate more easily upon infection. 
Dermatan sulfate, another GAG, has been shown to be released from host tissues 
following Psd infection and inhibit the antibacterial functioning of neutrophil released 
factors
28
. With this pathway downregulated, the initial immune response of mTBI 
leukocytes could be more effective than TT. This is because at the time of infection, it is 
likely there is less of the inhibitory dermatan sulfate present in mTBI lungs. With less 
inhibitory dermatan sulfate in the mTBI lungs as suggested by the downregulated 
pathway, the mTBI lungs could be an environment where leukocytes operate more 
effectively. 
Psd virulence related 
Gene sets indirectly involved in Psd virulence were downregulated in mTBI 
lungs. Psd causes tissue damage via exotoxin A which enters cells via receptor-mediated 
endocytosis
29,30
, a pathway that is downregulated in mTBI lungs (Figure 7).  
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Figure 7. Heatmap of the genes downregulated in mTBI (orange) vs. TT (gray) within 
the “Receptor Mediated Endocytosis” gene set. Receptor mediated endocytosis is a 
proposed mechanism of entry for Psd’s virulent exotoxin A into host cells. 
Downregulation of this pathway could inhibit one mechanism of damage Psd utilizes, 
possibly providing protection to mTBI lungs. (red and blue = upregulated and 
downregulated compared to mean expression, respectively) 
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It is believed that Psd produces extracellular phospholipase C (PLC) that is 
secreted through its inner membrane and is thought to be another contributing factor to its 
virulence
31,32
. In mTBI lungs, the host-derived components which manifest the effects 
triggered by exogenous PLC are downregulated in mTBI lungs (“Reactome PLC 
Mediated Cascade, NES = −1.60, p = 0.0384, FDR q = 0.1530). This could be beneficial 
to the mTBI mice because the PLC produced by the pathogen, which is usually 
detrimental in the host, could be less effective as the downstream pathway triggered by 
the pathogen-produced PLC is downregulated in mTBI lungs.  
Also of interest is the downregulation of pathways related to proteins that Psd 
could use to adhere to the epithelium to initiate infection, like laminin (Figure 8). With 
fewer messages being sent to produce these proteins, the Psd could have a more difficult 
time initiating an infection, possibly contributing to the increased survival of the mTBI 
mice. 
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Figure 8. Heatmap of the genes downregulated in mTBI (orange) vs. TT (gray) within 
the “Extracellular Matrix Part” gene set. Lamc1, Lamb1, Lamb2, Lama3 are all genes 
related to the basement membrane protein Laminin, which Psd is thought to use as an 
attachment point to initiate infections. (red and blue = upregulated and downregulated 
compared to mean expression, respectively) 
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DISCUSSION 
 
 A large portion of gene sets that were upregulated in mTBI lungs were pathways 
related to ATP synthesis or mitochondrial structure and organization. These upregulated 
gene sets imply the enhanced production of ATP which could have multiple beneficial 
effects on the innate immune system once challenged with Psd. If the mTBI lungs prior 
to infection are more bio-energetically prepared than TT lungs at 48 hours, once the 
pathogenic insult occurs, it is likely that the mTBI lungs can more effectively create a 
chemotactic response via cytokine production. It is thought that there are low levels of 
extracellular ATP existing in a “halo” around normal resting cells33. Based on the genetic 
expression of mTBI lungs, it is reasonable to believe that the resting cells in mTBI lungs 
could have more extracellular ATP existing in this “halo”. This low level of normal 
extracellular ATP, higher in the mTBI lungs, can have a beneficial effect on the immune 
system. This is because low levels of extracellular ATP have a chemotactic effect on 
neutrophils, monocytes, macrophages, and immature dendritic cells
34
, implying that there 
could be more chemotaxis to mTBI lungs by immune responders once an influx of 
chemokines is released after infection, allowing mTBI to combat the infection more 
effectively, accounting for increased survival. 
Additionally, increased oxidative phosphorylation is thought to raise the amount 
of reactive oxygen species (ROS) available to the immune system
35
. ROS production is 
crucial for the ability of neutrophils and macrophages to phagocytose and eradicate 
bacteria effectively
36,37
. With more genetic expression suggesting an increase in electron 
movement through oxidative phosphorylation in the lungs of mTBI mice, it is possible 
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mTBI lungs have more production of ROS in their eukaryotic cells
35
. Given the method 
for RNA extraction in this experiment, it is unclear where this possible increase in ROS is 
stemming from. Since entire sections of lung were removed and homogenized, this 
increase in ROS production could be either in the epithelial cells of the lung or within 
immune cells which happened to be included in the lung digest. If the possible increased 
ROS was sourced from immune cells trapped in the digest, this suggests that the mTBI 
neutrophils are better equipped to eradicate an infection. If the ROS production is in the 
epithelial cells of the lung, it is unclear if these cells could transfer ROS to the immune 
responders and thus provide them with an enhanced killing ability.  
Innate immune system responders can be triggered by damage-associated 
molecular patterns (DAMPs). DAMPs are endogenous cellular components that are 
released from damaged or necrotic cells after tissue damage resulting from non-
pathogenic or pathogenic sources
38
. DAMPs serve as a warning signal to the organism 
that a dangerous situation has developed which is destroying the cell and thus, they 
recruit immune cells to clear the damage or pathogen. DAMPs are derived from the 
nucleus, cytoplasm, exosomes, extracellular matrix, and plasma
38
. There are also non-
protein DAMPs such as uric acid, RNA, DNA, and ATP
39
. With genetic expression of 
ATP production pathways being significantly upregulated compared to TT lungs, it is 
possible that the mTBI lungs are filled with more ATP at 48 hours. So, upon infection 
with Psd at the 48 hour time point, the cellular damage caused by the pathogen could 
result in a far larger release of DAMPs (i.e. ATP) in the mTBI lungs.  
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ATP, now extracellular and acting as a DAMP due to the damage from 
pneumonia, has a number of augmenting effects on the innate immune system. 
Extracellular ATP acts as a chemotactic agent for neutrophils, as seen when injected 
intraperitoneally into mice
40
. In addition to the neutrophils recruited solely by ATP in 
these mice, the levels of MIP-2 and KC, two mouse chemokines, were also shown to 
increase. This is supported by a separate study showing that extracellular ATP triggers 
macrophages to release MIP-2 and increase migration of neutrophils to the site of ATP
40
. 
Thus, two chemotactic molecules are generated in addition to the chemotactic 
extracellular ATP, vastly increasing the potential number of recruited neutrophils to the 
site of ATP release. Upon lung damage after Psd, it is likely the increased neutrophil 
recruitment we see in mTBI lungs could be in part due to higher levels of the chemotactic 
extracellular ATP. 
While migration of neutrophils to the site of damage is increased by extracellular 
ATP, once the neutrophils have arrived, the larger amounts of extracellular ATP in mTBI 
lungs could increase their adhesion to the endothelial cells, an effect supported by 
numerous sources
41, 42,43,44,45,46,47
. Specifically, the increased levels of extracellular ATP 
likely to be found in mTBI lungs have been shown to act through the P2X7 receptor to 
activate (NF)-κB, which upregulates E-selectin, a protein necessary to initiate the rolling 
of neutrophils
48,49
, a crucial step involved in extravasation.  
Extracellular ATP not only increases the number of neutrophils at the site of its 
release, it is suggested to increase the effectiveness of the neutrophil’s bacterial clearance 
ability by increasing the production of superoxide, a component of ROS
50
. Our gene set 
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data supports the hypothesis that the cells in mTBI lungs at 48 hours have greater levels 
of ATP which could provide more energy to the lung for a more robust immune response 
than TT lungs once they receive pneumonia. However, once the pneumonia has started 
damaging cells, the data supports the hypothesis that mTBI lungs will release far more 
ATP, due to the upregulation of ATP synthesis gene sets, which can then act as a 
chemotactic and immune augmenting DAMP. With more extracellular ATP in mTBI 
lungs, there could be enhanced recruitment, better extravasation into the lung space, and 
increased killing ability of neutrophils to fight the infection, leading to a more effective 
immune response and our observed increased survival of mTBI mice. This hypothesized 
mechanism of action is supported by our previous work which shows increased numbers 
of neutrophils and decreased bacterial colony forming units (CFUs) in the 
bronchoalveolar lavage of mTBI lungs 4 hours after pneumonia insult
7
. 
Interestingly, the majority of gene sets were downregulated in mTBI lungs and 
most functions involved inter-cell, intra-cell, and extracellular connections and 
organization. Epithelial cells of mTBI lungs could have an altered organization, structure, 
and connection compared to TT, possibly providing an environment for quicker 
extravasation of circulating leukocytes to the airspace following Psd infection.  
Psd infections begin with adhesion to the endothelial cells in the lung
51
. While 
many of these connections are still unknown, there is some literature support for Psd 
utilizing cellular components which are downregulated in the mTBI lungs according to 
GSEA. In particular, Psd has been suggested to adhere to extracellular matrix proteins of 
the epithelium, like laminin, which constitute the basement membrane of epithelial cells 
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and are revealed upon cellular damage
52
. Many of the genes for laminin are 
downregulated in the “Extracellular Matrix Part” gene set seen in Figure 7. Given that the 
gene set is downregulated in mTBI lungs, it is possible there are fewer of these proteins 
in the epithelial cells. So, after they are damaged by the infection, in mTBI lungs the cells 
could have fewer proteins like laminin, leading to a decreased ability of Psd to adhere to 
lungs. This could interfere with their mechanism of infection, making them less virulent 
and easier to phagocytose than the Psd which could securely attach to the extracellular 
matrix proteins in TT lungs. Glycosaminoglycans are polysaccharides consisting of 
disaccharides made of amino and uronic sugars
53
. One amino sugar which makes up 
glycosaminoglycans is N-Acetylglucosamine, which has been suggested as a molecule 
which Psd can attach to, allowing the initiation of infection
54
. Supporting the increased 
survival of mTBI mice due to a smaller bacterial burden, mTBI lungs had multiple 
glycosaminoglycan pathways downregulated, suggesting the expression of fewer 
attachment points for Psd in these mice.   
The combination of increased upregulation of ATP and mitochondrial gene sets as 
well as downregulated Psd virulence related sets in mTBI lungs could lead to an 
environment better suited to fighting an infection than blunt trauma. While the cause of 
these genetic changes is unknown, it is likely they are based off the downstream effects 
of the mTBI and subsequent release of SP. A limitation of the study is the RNA extracted 
and measured are just instructions for the cells to produce proteins. Whether or not the 
instructions are carried out, and the desired protein is actually manufactured, is unknown. 
However, the differences in RNA expression of these genes are significant and therefore 
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it is likely that even if all of the RNA is not being translated, in mTBI, these messages are 
becoming translated into protein more frequently than TT. This assumption can be made 
given that in our previous experiments, we have shown that there is an increase in 
survival of mTBI mice when challenged with pneumonia
7,8
.  
Future studies will examine the more tangible aspects of the upregulated gene 
sets. To determine if the message for ATP and mitochondria is being translated into a real 
result, ATP will be measured in the mTBI lungs 48 hours after trauma using one of the 
many available commercial assays. To determine if the downregulated gene sets are 
being reflected beyond just the genetic message, lung leakage 48 hours after trauma will 
be assessed in mTBI lungs with two protein assays to assess lung leakage. The first 
procedure will be a Bradford assay of the BAL at 48 hours to measure large molecular 
leakage into the airspace. The second will be intravenous administration of Evans Blue 
via the tail vein prior to mTBI followed by sacrifice and BAL 4, 24, and 48 hours 
afterwards to assess the amount of albumin (which Evans Blue binds to) that has passed 
from circulation into the lung space. Histology will also be performed and assessed to 
determine if there is any identifiable separation in inter- and intra-cellular junctions in 
mTBI lungs. We would hope to see higher levels of protein and albumin in the BAL of 
mTBI mice and large inter-cellular junctions to support the hypothesis that the mTBI 
lungs are “leakier” and thus allow neutrophils easier entry into the airspace once infected 
with pneumonia, contributing to their increased survival. 
While many experiments need to be done to confirm the findings, based off the 
significance of the statistical analysis of the microarray data, it is likely that the 
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environment in which the mTBI mice mount their immune response is more energetically 
prepared and tailored for a successful eradication of the pathogen and thus is likely a 
contributing factor to our increased survival findings.  
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